Live from the NIH registry
Studies recruiting near Baton Rouge right now
Top 25 of 217 recruiting studies, sorted by proximity — each links to its official registry page
Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design
Fibromyalgia
Phase 3
Interventional 620 participants sought
Clinical Research Site — Prairieville, Louisiana (13.5 mi)
· Sponsor: Axsome Therapeutics, Inc.
A Study of Dotinurad Versus Allopurinol in Participants With Gout
Gout
Phase 3
Interventional 500 participants sought
DelRicht Research - Prairieville — Prairieville, Louisiana (13.5 mi)
· Sponsor: Crystalys Therapeutics
Impact of Lean Pork on Endothelial Function in Perimenopause
Cardiovascular Outcome, Overweight and Obese Women
N/A
Interventional 30 participants sought
Pennington Biomedical Research Center — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: Pennington Biomedical Research Center
Cardiovascular Risk and Circadian Misalignment in Short Sleepers - Role of Extended Eating Period
Sleep Deprivation
N/A
Interventional 100 participants sought
Recruiting core Pennington — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: Pennington Biomedical Research Center
ZEN003694 and Enzalutamide Versus Enzalutamide Monotherapy in Metastatic Castration-Resistant Prostate Cancer
Metastatic Castration-Resistant Prostate Cancer
Phase 2
Interventional 200 participants sought
Hematology Oncology Clinic — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: Zenith Epigenetics
Nutrition for Asthmatics
Asthma
N/A
Interventional 15 participants sought
Pennington Biomedical Research Center — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: Pennington Biomedical Research Center
Collaborative Multi-level Obesity Intervention Engaging Underserved Communities Trial
Obesity
N/A
Interventional 522 participants sought
CareSouth Medical and Dental - Baton Rouge Clinic — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: Tulane University
Study Assessing Activity of Intravenous (IV) Etentamig Monotherapy Versus Standard Available Therapies in Adult Participants With Relapsed or Refractory Multiple Myeloma
Multiple Myeloma
Phase 3
Interventional 380 participants sought
Our Lady Of The Lake Regional Medical Center /ID# 272780 — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: AbbVie
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
Acute Myeloid Leukemia
Phase 2
Interventional 93 participants sought
Our Lady of the Lake Physician Group — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: National Cancer Institute (NCI)
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Plasma Cell Myeloma, RISS Stage I Plasma Cell Myeloma
Phase 3
Interventional 1,450 participants sought
LSU Health Baton Rouge-North Clinic — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma
Classic Follicular Lymphoma, Follicular Lymphoma With Unusual Cytological Features
Phase 3
Interventional 600 participants sought
LSU Health Baton Rouge-North Clinic — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: National Cancer Institute (NCI)
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm
Phase 2
Interventional 2,000 participants sought
LSU Health Baton Rouge-North Clinic — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Moderately to Severely Active Crohns Disease
Phase 3
Interventional 425 participants sought
Baton Rouge General Medical Center — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: Hoffmann-La Roche
A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy
Breast Cancer, Early Breast Cancer
Phase 3
Interventional 4,300 participants sought
Research Site — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: AstraZeneca
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer
Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7
Phase 2, Phase 3
Interventional 613 participants sought
LSU Health Baton Rouge-North Clinic — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: National Cancer Institute (NCI)
A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE)
Systemic Lupus Erythematosus
Phase 4
Interventional 350 participants sought
GSK Investigational Site — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: GlaxoSmithKline
A Study to Evaluate the Optimization of the Cytokine Release Syndrome Profile for Glofitamab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed/Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma
B-Cell Non-Hodgkins Lymphoma
Phase 2
Interventional 100 participants sought
Mary Bird Perkins Cancer Ctr — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: Hoffmann-La Roche
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
Oligometastatic Prostate Cancer (OMPC)
Phase 3
Interventional 450 participants sought
Mary Bird Perkins Cancer Center — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: Novartis Pharmaceuticals
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
Non Small Cell Lung Cancer
Phase 3
Interventional 780 participants sought
LSU Health Baton Rouge North Clinic ( Site 4003) — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: Merck Sharp & Dohme LLC
Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer
Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
Phase 2
Interventional 180 participants sought
LSU Health Baton Rouge-North Clinic — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: National Cancer Institute (NCI)
Fabry Disease Registry & Pregnancy Sub-registry
Fabry Disease
N/A
Observational 9,000 participants sought
Ochsner Health Center - Baton Rouge- Site Number : 840120 — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: Genzyme, a Sanofi Company
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Prostate Cancer (Adenocarcinoma)
Phase 3
Interventional 830 participants sought
Louisiana Hematology Oncology Associates LLC — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: Canadian Cancer Trials Group
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
Overweight, Obesity
Phase 3
Interventional 460 participants sought
Pennington Biomed Res Ctr — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: Novo Nordisk A/S
Testing the Addition of Lenalidomide and Nivolumab to the Usual Treatment for Primary CNS Lymphoma
Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System
Phase 1
Interventional 47 participants sought
LSU Health Baton Rouge-North Clinic — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: National Cancer Institute (NCI)
Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne
Acne
Phase 1, Phase 2
Interventional 800 participants sought
Louisiana Dermatology Associates- Site Number : 8400043 — Baton Rouge, Louisiana (3.4 mi)
· Sponsor: Sanofi Pasteur, a Sanofi Company